Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Larimar Therapeutics, Inc.”

5 pharma patents match "Larimar Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 5
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 5 pharmaceutical patents matching "Larimar Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

5 results for “Larimar Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 12390509

    Pharmaceutical composition comprising frataxin fusion protein and methods of use thereof

    Larimar Therapeutics, Inc. · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  2. US 12351611

    Molecules for organelle-specific protein delivery

    Larimar Therapeutics, Inc. · Granted Jul 8, 2025 · Expires Jul 3, 2045

    granted
  3. US 12091437

    Molecules for organelle-specific protein delivery

    Larimar Therapeutics, Inc. · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted
  4. US 11976100

    Methods for treating myelin associated diseases and mitochondria associated diseases

    Larimar Therapeutics, Inc. · Granted May 7, 2024 · Expires May 2, 2044

    granted
  5. US 11891420

    Molecules for organelle-specific protein delivery

    Larimar Therapeutics, Inc. · Granted Feb 6, 2024 · Expires Feb 1, 2044

    granted